Xencor Inc

XNCR remains in a Stage 3 distribution phase with price below declining 9- and 20-period EMAs, confirming a medium-term bearish bias. Short-term weakness and rejection at those EMAs support a Sell Now execution on rallies into resistance, while the long-term uptrend stays intact above the 200-day SMA. A decisive close and follow-through above the 20-day EMA would invalidate the bearish bias.

• ↑XmAb819 delivered 25% response rate in advanced RCC; pivotal studies due 2027
• ↑Secured $105M Ultomiris royalty agreement, extending cash runway to mid-2028
• ↓Reported Q2 loss of $0.81 per share on $17.5M revenue, missing estimates